Regulation of anti-tumor immunity by targeting cyclooxygenase-2 expressing cells
| Project/Area Number |
23701076
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Tumor immunology
|
|---|
| Research Institution | Kyoto University (2012-2013)
Kitasato University (2011) |
|---|
Principal Investigator |
INOUE Joe 京都大学, 医学(系)研究科(研究院), 助教 (00433714)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | cox-2 / tumor / dendritic cell / liposome / COX-2 |
|---|
| Research Abstract |
The immunosuppression in tumor tissue has been attributed to tumor cells expressing cyclooxygenase (COX) -2. From this study, COX-2 was also expressed in tumor infiltrated CD11c+ cells. It was shown that through the production of immunosuppressive cytokines by COX-2+CD11c+ cells, the cells are largely responsible for immunosuppression in tumor tissues. Moreover, liposome (COX-2 selective inhibitors encapsulated liposome) which newly prepared to target the COX-2+CD11c+ cells, it showed the possibility to improve the immunosuppression by COX-2+CD11c + cells in tumor tissues.
|
Report
(4 results)
Research Products
(6 results)
